Physician

Michael Engelbert, MD

According to 2025 Medicare claims, Michael Engelbert, MD (NPI: 1699945543) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Westchester, NY. This provider's primary affiliated billing organization is VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK (NPI: 1598700791; TIN: 132721177) and primary practice location at 10604-2922.

Engelbert's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,378 traditional Medicare patients, billed 68,471 HCPCS/CPT codes, and received $2,774,242 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 1,101 prescription claims across 373 beneficiaries totaling $194,831 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 35 records totaling $13,764. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,425,057 to $2,774,242. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $75,232 and ending at $194,831. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2015 Medicare payment: $1,425,057 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,549,050 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,575,128 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,887,102 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,037,339 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,660,077 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,858,349 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,211,642 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,665,059 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,774,242 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156537,611$1,425,057
20166698,696$1,549,050
20176948,892$1,575,128
201878610,629$1,887,102
201977611,681$2,037,339
20206418,066$1,660,077
20218079,776$1,858,349
202292518,586$2,211,642
20231,17151,334$2,665,059
20241,37868,471$2,774,242

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$107K$213K2015 Drug cost: $75,232 (USD; Tot_Drug_Cst)2016 Drug cost: $77,823 (USD; Tot_Drug_Cst)2017 Drug cost: $128,552 (USD; Tot_Drug_Cst)2018 Drug cost: $61,959 (USD; Tot_Drug_Cst)2019 Drug cost: $35,985 (USD; Tot_Drug_Cst)2020 Drug cost: $34,886 (USD; Tot_Drug_Cst)2021 Drug cost: $49,025 (USD; Tot_Drug_Cst)2022 Drug cost: $107,506 (USD; Tot_Drug_Cst)2023 Drug cost: $213,261 (USD; Tot_Drug_Cst)2024 Drug cost: $194,831 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015139499$75,232
2016156455$77,823
2017123338$128,552
201881231$61,959
201986263$35,985
202085223$34,886
202173247$49,025
2022197532$107,506
2023284787$213,261
20243731,101$194,831

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system307307$123
92014Established patient complete exam of visual system589636$111
92012Established patient problem focused exam of visual system7811,918$82
92134Imaging of retina1,3422,890$37
92250Photography of the retina1,1291,286$34

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine773,900$69,817
XiidraLifitegrast22780$17,331
ProlensaBromfenac Sodium29989$11,493
Prednisolone AcetatePrednisolone Acetate1507,569$9,019
CyclosporineCyclosporine291,170$8,906

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$13,764F. Hoffmann-La Roche AG
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Engelbert, MD?

Tedicare shows public-source Medicare data for Michael Engelbert, MD (NPI 1699945543), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Engelbert, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Engelbert, MD?

Michael Engelbert, MD is linked to VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK (billing NPI 1598700791) in the available physician profile data.

Does Michael Engelbert, MD have Open Payments data?

Michael Engelbert, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.